Browse
Submit Data
Databases
API
Help

Dataset Information

35 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

3-Iodo-1H-pyrazolo-[3,4-b]pyridine.

ABSTRACT: The title compound, C6H4IN3, is essentially planar, with a dihedral angle of 0.82?(3)° between the planes of the pyridine and pyrazole rings. In the crystal, pairs of mol-ecules are connected into inversion dimers through N-H?N hydrogen bonds. C-I?N halogen bonds link the dimers into zigzag chains parallel to the b-axis direction. The packing also features ?-? stacking inter-actions along (110) with inter-planar distances of 3.292?(1) and 3.343?(1)?Å, and centroid-centroid distances of 3.308?(1) and 3.430?(1)?Å.

SUBMITTER: Huang PH

PROVIDER: S-EPMC4051060 | biostudies-literature | 2014 Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

3-Iodo-1H-pyrazolo-[3,4-b]pyridine.

Huang Ping-Hsin PH Wen Yuh-Sheng YS Shen Jiun-Yi JY

Acta crystallographica. Section E, Structure reports online 20140510 Pt 6

The title compound, C6H4IN3, is essentially planar, with a dihedral angle of 0.82 (3)° between the planes of the pyridine and pyrazole rings. In the crystal, pairs of mol-ecules are connected into inversion dimers through N-H⋯N hydrogen bonds. C-I⋯N halogen bonds link the dimers into zigzag chains parallel to the b-axis direction. The packing also features π-π stacking inter-actions along (110) with inter-planar distances of 3.292 (1) and 3.343 (1) Å, and centroid-centroid distances of 3.308 (1) ...[more]

PMID: 24940235

Similar Datasets

3,4,6-Trimethyl-1-phenyl-1H-pyrazolo-[3,4-b]pyridine.

Project description:In the title compound, C(15)H(15)N(3), the 1H-pyrazolo-[3,4-b]pyridine system and the phenyl ring are each individually planar, with r.m.s. deviations of 0.017?(2) and 0.011?(2)?Å, respectively; the dihedral angle between the two aromatic systems is 9.33?(10)°. The crystal packing is stabilized by offset ?-? stacking between parallel pyrazolo-[3,4-b]pyridine ring systems [face-to-face distance = 3.449?(6)?Å].

| S-EPMC3007300 | biostudies-literature

Structural Basis for PPAR? Activation by 1H-pyrazolo-[3,4-b]pyridine Derivatives.

Project description:Small-molecule agonism of peroxisome proliferator-activated receptor ? (PPAR?), a ligand-activated transcriptional factor involved in regulating fatty acid metabolism, is an important approach for treating dyslipidemia. Here, we determined the structures of the ligand-binding domain (LBD) of PPAR? in complex with 1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid derivatives, which were recently identified as PPAR?-selective activators with markedly different structures from those of the well-known PPAR? agonists fibrates. The crystal structures of the complexes showed that they form a canonical hydrogen-bond network involving helix 12 in the LBD, which is thought to be essential for PPAR? activation, as also observed for fibrates. However, the phenyl side chain of the compounds occupies a small cavity between Ile272 and Ile354, which is rarely accessed by fibrates. This unique feature may be essential for subtype selectivity and combine with the well-characterized binding mode of fibrates to improve activity. These findings demonstrate the advantage of using 1H-pyrazolo-[3,4-b]pyridine as a skeleton of PPAR? agonists and provide insight into the design of molecules for treating dyslipidemia.

| S-EPMC7203124 | biostudies-literature

Discovery of Substituted 1H-Pyrazolo[3,4-b]pyridine Derivatives as Potent and Selective FGFR Kinase Inhibitors.

Project description:Fibroblast growth factor receptors (FGFRs) are important targets for cancer therapy. Herein, we describe the design, synthesis, and biological evaluation of a novel series of 1H-pyrazolo[3,4-b]pyridine derivatives as potent and selective FGFR kinase inhibitors. On the basis of its excellent in vitro potency and favorable pharmacokinetic properties, compound 7n was selected for in vivo evaluation and showed significant antitumor activity in a FGFR1-driven H1581 xenograft model. These results indicated that 7n would be a promising candidate for further drug development.

| S-EPMC4904267 | biostudies-literature

4-Benzyl-sulfanyl-1H-pyrazolo-[3,4-d]pyrimidine.

Project description:The pyrazolo-[3,4-d]pyrimidine ring system of the title compound, C12H10N4S, is essentially planar [maximum deviation = 0.025?(1)?Å for the C atom bearing the S atom] and almost perpendicular to the phenyl ring [dihedral angle = 71.42?(6)°]. In the crystal, mol-ecules are linked via pairs of N-H?N hydrogen bonds, forming inversion dimers.

| S-EPMC3884315 | biostudies-literature

Crystal structure of 3-methyl-1-phenyl-6-propyl-amino-1H-pyrazolo[3,4-b]pyridine-5-carbo-nitrile.

Project description:In the title compound, C17H17N5, the dihedral angle between the 1H-pyrazolo-[3,4-b]pyridine ring system (r.m.s. deviation = 0.001 Å) and the attached phenyl group is 2.56 (6)°. The propyl-amino side chain has a contorted conformation [Car-N-C-C = -77.97 (16)° and N-C-C-C = -57.37 (17)°]. An intra-molecular C-H⋯N inter-action closes an S(6) ring. In the crystal, inversion dimers linked by pairs of N-H⋯N hydrogen bonds generate R 2 (2)(12) loops. Aromatic π-π stacking inter-actions [centroid-centroid distance = 3.5726 (8) Å] are also observed.

| S-EPMC4647426 | biostudies-literature

3-Methyl-1,4-diphenyl-1H-pyrazolo-[3,4-b]quinoline.

Project description:In the title mol-ecule, C(23)H(17)N(3), the phenyl substituents at positions 1 and 4 are twisted relative to the central core by 27.09?(5) and 66.62?(4)°, respectively. In the crystal, mol-ecules are assembled into centrosymmetric dimers via ?-? stacking inter-actions between the 1H-pyrazolo-[3,4-b]quinoline -units, with an inter-planar distance of 3.601?(2)?Å and by weak inter-molecular C-H?N inter-actions.

| S-EPMC3009067 | biostudies-literature

6,7-Dihydro-4-(4-methoxy-phen-yl)-3-methyl-6-oxo-1-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile.

Project description:In the title compound, C(21)H(16)N(4)O(2), the dihedral angle between the meth-oxy-substituted benzene ring and the ring system formed by the pyridinone ring and the pyrazole ring is 57.4?(1)°, and that between the unsubstituted phenyl ring and the ring system is 135.6?(1)°. In the crystal structure, mol-ecules are linked together via inter-molecular N-H?O hydrogen bonds.

| S-EPMC2959259 | biostudies-literature

1,3-Diphenyl-8-trifluoro-methyl-1H-pyrazolo-[3,4-b]quinoline.

Project description:The 1H-pyrazolo-[3,4-b]quinoline (PQ) core of the title mol-ecule, C(23)H(14)F(3)N(3), is aromatic and essentially planar (r.m.s. deviation = 0.015 Å) and the two phenyl substituents at positions 1 and 3 are twisted relative to this fragment by 29.74 (7) and 25.63 (7)°, respectively. In the crystal, mol-ecules are arranged along the b axis into stacks via π-π inter-actions, with an inter-planar distance of the PQ core of 3.489 (4) Å.

| S-EPMC3394066 | biostudies-literature

4-(4-Bromo-phen-yl)-3-methyl-1-phenyl-6,7-dihydro-1H-pyrazolo-[3,4-b]thieno[2,3-e]pyridine 5,5-dioxide.

Project description:In the title compound, C(21)H(16)BrN(3)O(2)S, the pyrazole and pyridine rings are nearly coplanar, the dihedral angle between their planes being 3.17 (14)°. The 2,3-dihydro-thio-phene ring adopts an envelope conformation. The 4-bromo-phen-yl/pyridine ring and phen-yl/pyrazole rings form dihedral angles of 60.06 (9) and 33.49 (11)°, respectively. There is an intra-molecular C-H⋯N hydrogen bond. The crystal packing is stabilized by inter-molecular C-H⋯O hydrogen bonding and C-H⋯π inter-actions.

| S-EPMC3238837 | biostudies-literature

Four-component bicyclization approaches to skeletally diverse pyrazolo[3,4-b]pyridine derivatives.

Project description:A novel four-component bicyclization strategy has been established, allowing a flexible and practical approach to 37 examples of multicyclic pyrazolo[3,4-b]pyridines from low-cost and readily accessible arylglyoxals, pyrazol-5-amines, aromatic amines, 4-hydroxy-6-methyl-2H-pyran-2-one, and cyclohexane-1,3-diones. The polysubstituted cyclopenta[d]pyrazolo[3,4-b]pyridines were stereoselectively synthesized through a microwave-assisted special [3+2+1]/[3+2] bicyclization with good control of the spatial configuration of exocyclic double bonds. The novel [3+2+1]/[2+2+1] bicyclization resulted in 17 examples of unreported pyrazolo[3,4-b]pyrrolo[4,3,2-de]quinolones. Reasonable mechanisms for forming two new types of multicyclic pyrazolo[3,4-b]pyridines are also proposed.

| S-EPMC4242041 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data